FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,756,000 | +551.5% | 162,000 | +80.0% | 0.09% | +447.1% |
| Q3 2020 | $423,000 | -23.0% | 90,000 | 0.0% | 0.02% | -29.2% |
| Q2 2020 | $549,000 | +169.1% | 90,000 | 0.0% | 0.02% | +118.2% |
| Q1 2020 | $204,000 | -50.6% | 90,000 | 0.0% | 0.01% | -35.3% |
| Q4 2019 | $413,000 | +18.3% | 90,000 | 0.0% | 0.02% | +13.3% |
| Q3 2019 | $349,000 | -35.7% | 90,000 | 0.0% | 0.02% | -40.0% |
| Q2 2019 | $543,000 | -55.0% | 90,000 | 0.0% | 0.02% | -55.4% |
| Q1 2019 | $1,206,000 | +44.1% | 90,000 | 0.0% | 0.06% | +40.0% |
| Q4 2018 | $837,000 | -33.2% | 90,000 | 0.0% | 0.04% | -29.8% |
| Q3 2018 | $1,253,000 | -11.9% | 90,000 | 0.0% | 0.06% | +1.8% |
| Q2 2018 | $1,423,000 | -8.0% | 90,000 | 0.0% | 0.06% | -9.7% |
| Q1 2018 | $1,546,000 | -11.9% | 90,000 | +12.5% | 0.06% | -7.5% |
| Q4 2017 | $1,754,000 | – | 80,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|